TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
PMVP

Pmv Pharmaceuticals Inc

Healthcare · Biotechnology

1.50$ +2.1% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Pmv Pharmaceuticals Inc (PMVP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 90.6% of the shares are freely tradable; institutional investors hold 69.5%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 69.5%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 3.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 90.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 54Mio.

Largest Shareholders

Institutions

Institutions PMVP
Name Stake (%) Shares Change (%) Date
BML Capital Management LLC 9.99 5,330,000 +0.2 06/30/2026
TANG CAPITAL MANAGEMENT LLC 7.96 4,245,085 -14.1 03/31/2026
Sio Capital Management, LLC 4.94 2,634,137 -14.4 06/30/2026
Euclidean Capital LLC 4.93 2,627,643 +0.0 06/30/2026
Adage Capital Partners Gp LLC 4.43 2,360,000 +26.9 06/30/2026
Acadian Asset Management LLC 4.15 2,215,894 +0.0 03/31/2026
Vanguard Capital Management, LLC 3.70 1,974,906 +0.0 03/31/2026
ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 3.67 1,959,579 -31.8 06/30/2026
Two Sigma Investments LLC 3.66 1,954,136 +3.7 06/30/2026
Eversept Partners, LP 3.55 1,890,904 -19.5 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?